PCI With AXXESS Biolimus A9 Eluting Bifurcation Stent in Treating Coronary Artery Bifurcation Disease
NCT02384629 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL
Last updated 2016-07-27
Summary
1. To compare the safety and efficacy of AXXESS stent with conventional DES in patients with coronary artery bifurcation disease
2. To assess the impact of optical coherence tomography (OCT) guidance on clinical outcomes following the stent type
Conditions
- Coronary Bifurcation Lesions
Interventions
- DEVICE
-
OCT-guided PCI with AXXESS stent
The AXXESS stent (Biosensors Europe SA, Morges, Switzerland) is a dedicated self-expanding bifurcation stent eluting the sirolimus analog Biolimus A9 emulsed in a biodegradable polymer. It has the advantage to preserve the ostium of both distal branches and allows additional stent implantation in the distal branches for complete lesion coverage, while reducing large stent overlap and eliminating deformation. Optical coherence tomography (OCT), has enabled the evaluation of strut coverage and arterial healing after DES implantation with a superior resolution and delineation over other imaging modalities. With using these superiorities of OCT, there have been many studies assessing the neointimal coverage following various types of DES implantation in various periods.
- DEVICE
-
OCT-guided PCI with conventional DES (Biomatrix flex stent)
BioMatrix Flex is abluminal biodegradable polymer DES. Its abluminal coating is absorbed after 6 to 9months and turns the DES into a BMS. It combines the proven safety of a DES with an abluminal biodegradable polymer, the prove efficacy of BA9 and an advanced stent design. Optical coherence tomography (OCT), has enabled the evaluation of strut coverage and arterial healing after DES implantation with a superior resolution and delineation over other imaging modalities. With using these superiorities of OCT, there have been many studies assessing the neointimal coverage following various types of DES implantation in various periods.
- DEVICE
-
Angio-guided PCI with AXXESS stent
The AXXESS stent (Biosensors Europe SA, Morges, Switzerland) is a dedicated self-expanding bifurcation stent eluting the sirolimus analog Biolimus A9 emulsed in a biodegradable polymer. It has the advantage to preserve the ostium of both distal branches and allows additional stent implantation in the distal branches for complete lesion coverage, while reducing large stent overlap and eliminating deformation. We use the conventional coronary angiography.
- DEVICE
-
Angio-guided PCI with PCI with conventional DES (Biomatrix flex stent)
BioMatrix Flex is abluminal biodegradable polymer DES. Its abluminal coating is absorbed after 6 to 9months and turns the DES into a BMS. It combines the proven safety of a DES with an abluminal biodegradable polymer, the prove efficacy of BA9 and an advanced stent design. We use the conventional coronary angiography.
Sponsors & Collaborators
-
Yonsei University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-03-31
- Primary Completion
- 2017-03-31
- Completion
- 2017-12-31
More Related Trials
-
Bifurcation Stenting Using 2 Link Stent Nobori Versus 3 Link Stent Xience
NCT01574586 ·Status: UNKNOWN ·Phase: NA
-
BGP+ Stent as Bridging Stent in BEVAR
NCT03982940 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Safety Study to Assess the Feasibility of Use in Humans of the TAXUS Petal Bifurcation Coronary Stent System
NCT00497367 ·Status: COMPLETED ·Phase: PHASE1
-
Coronary Bifurcation Lesions Treated With Biguard Stent System
NCT02597283 ·Status: WITHDRAWN ·Phase: NA
-
Triple-branch Stent Graft Placement for the Treatment of Acute DeBakey I Aortic Dissection
NCT02732340 ·Status: COMPLETED ·Phase: NA
-
BIOTRONIK - BIOFLOW-III Registry French Satellite
NCT02273648 ·Status: UNKNOWN
-
Plaque Stabilization and Restoration by Bioresorbable Vascular Scaffold
NCT02319733 ·Status: TERMINATED ·Phase: NA
-
A Randomized Controlled Comparison Between One Versus More Than Six Months of Dual Antiplatelet Therapy After Biolimus A9-eluting Stent Implantation
NCT02513810 ·Status: UNKNOWN ·Phase: NA
-
RelayPro Thoracic Stent-Graft in Subjects With Thoracic Aortic Aneurysms and Penetrating Atherosclerotic Ulcers
NCT02818972 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Bioresorbable Vascular Scaffolds Versus Stents in Patients With Chronic Total Occlusion
NCT02739685 ·Status: TERMINATED ·Phase: NA
-
Evaluation of the GTX™ 5126 DES Coronary Stent System in the Treatment of Patients With a Lesion in the Coronary Artery
NCT00777842 ·Status: TERMINATED ·Phase: NA
-
BGP Stent as Bridging Stent in FEVAR
NCT03987035 ·Status: COMPLETED ·Phase: NA
-
Early Feasibility Study of the RelayBranch Thoracic Stent-Graft System
NCT03214601 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Self-expanding Nitinol Stents of High vs. Low Chronic Outward Force in De-novo Femoropopliteal Occlusive Arterial Lesions
NCT03097679 ·Status: UNKNOWN ·Phase: NA
-
e-BioMatrix 6 Month DAPT France
NCT03461484 ·Status: COMPLETED
-
Feasibility of Endovascular Repair of Ascending Aortic Pathologies
NCT03322033 ·Status: TERMINATED ·Phase: NA
-
RESOLUTE ONYX Post-Approval Study (Bifurcation Cohort)
NCT03584464 ·Status: COMPLETED ·Phase: NA
-
HOW To Optimally Implant BioResorbable Scaffold - Intravascular Imaging Versus Quantitative Coronary Angiography Guidance
NCT03175523 ·Status: TERMINATED ·Phase: NA
-
BioFreedom™ BA9™ Ultra
NCT05331547 ·Status: UNKNOWN
-
LEADERS FREE II: BioFreedom™ Pivotal Study
NCT02843633 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Biofreedom Prospective Multicenter Observational Registry
NCT03045848 ·Status: TERMINATED
-
Sealing Moderate Coronary Saphenous VEin Graft Lesions With Paclitaxel-Eluting Stents
NCT01223443 ·Status: TERMINATED ·Phase: PHASE4
-
The Bioresorbable Implants for Scaffolding Obstructions in Randomized Bifurcations (BIFSORB) Study
NCT02973529 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
eTryton Left Main Registry Tryton Side Branch Stent® Tmt of Denovo CAD in LM and CFX Arteries
NCT02765646 ·Status: UNKNOWN
-
A Prospective, Multi-center, Single Arm Study Evaluating the Express™ Renal Premounted Stent System in the Treatment of Atherosclerotic Lesions in the Aortorenal Ostium.
NCT00597142 ·Status: COMPLETED ·Phase: PHASE4